 | • レポートコード：QYR9ST04383 • 出版社/出版日：QYResearch / 2019年9月2日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥569,400 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,138,800 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、自己免疫疾患治療の世界市場について調査・分析し、自己免疫疾患治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ブリッジセラピー、組換え技術、糞便細菌療法、造血幹細胞移植、光線療法、蠕虫療法、活性化誘発アッセイ、飛行時間型質量分析によるサイトメトリー）、用途別（全身性自己免疫疾患、限局性自己免疫疾患）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の自己免疫疾患治療市場動向 ・主要企業別マーケットシェア ・自己免疫疾患治療の種類別市場規模2014-2019 （ブリッジセラピー、組換え技術、糞便細菌療法、造血幹細胞移植、光線療法、蠕虫療法、活性化誘発アッセイ、飛行時間型質量分析によるサイトメトリー） ・自己免疫疾患治療の用途別市場規模2014-2019 （全身性自己免疫疾患、限局性自己免疫疾患） ・自己免疫疾患治療の北米市場：主要企業・種類別/用途別市場規模 ・自己免疫疾患治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・自己免疫疾患治療の中国市場：主要企業・種類別/用途別市場規模 ・自己免疫疾患治療の日本国内市場：主要企業・種類別/用途別市場規模 ・自己免疫疾患治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・自己免疫疾患治療のインド市場：主要企業・種類別/用途別市場規模 ・自己免疫疾患治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Abbott Laboratories、Roche Diagnostics、Siemens Healthcare、Johnson & Johnson、Boehringer Ingelheim、GlaxoSmithKline、AstraZeneca、Sanofi、Merck、Pfizer） ・自己免疫疾患治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Graves’ disease, Multiple sclerosis, Myasthenia gravis, Rheumatoid arthritis, Pernicious anemia and Systemic lupus erythematosus are the most prevalent types of autoimmune disorders. The prevalence of autoimmune diseases is high in women than in men, which results from the influence of estrogen on immune system.In 2018, the global Autoimmune Disorders Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Autoimmune Disorders Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Autoimmune Disorders Treatment development in United States, Europe and China.
The key players covered in this study
Abbott Laboratories
Roche Diagnostics
Siemens Healthcare
Johnson & Johnson
Boehringer Ingelheim
GlaxoSmithKline
AstraZeneca
Sanofi
Merck
Pfizer
Market segment by Type, the product can be split into
Bridge therapy
Recombinant technology
Fecal bacteriotherapy
Hematopoietic stem-cell transplantation
Phototherapy
Helminthic therapy
Activation-induced assays
Cytometry by time-of-flight mass spectrometry
Market segment by Application, split into
Systemic autoimmune diseases
Localized autoimmune diseases
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Autoimmune Disorders Treatment status, future forecast, growth opportunity, key market and key players.
To present the Autoimmune Disorders Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Autoimmune Disorders Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Autoimmune Disorders Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Bridge therapy
1.4.3 Recombinant technology
1.4.4 Fecal bacteriotherapy
1.4.5 Hematopoietic stem-cell transplantation
1.4.6 Phototherapy
1.4.7 Helminthic therapy
1.4.8 Activation-induced assays
1.4.9 Cytometry by time-of-flight mass spectrometry
1.5 Market by Application
1.5.1 Global Autoimmune Disorders Treatment Market Share by Application (2014-2025)
1.5.2 Systemic autoimmune diseases
1.5.3 Localized autoimmune diseases
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Autoimmune Disorders Treatment Market Size
2.2 Autoimmune Disorders Treatment Growth Trends by Regions
2.2.1 Autoimmune Disorders Treatment Market Size by Regions (2014-2025)
2.2.2 Autoimmune Disorders Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Autoimmune Disorders Treatment Market Size by Manufacturers
3.1.1 Global Autoimmune Disorders Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Autoimmune Disorders Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Autoimmune Disorders Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Autoimmune Disorders Treatment Key Players Head office and Area Served
3.3 Key Players Autoimmune Disorders Treatment Product/Solution/Service
3.4 Date of Enter into Autoimmune Disorders Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Autoimmune Disorders Treatment Market Size by Type (2014-2019)
4.2 Global Autoimmune Disorders Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Autoimmune Disorders Treatment Market Size (2014-2019)
5.2 Autoimmune Disorders Treatment Key Players in United States
5.3 United States Autoimmune Disorders Treatment Market Size by Type
5.4 United States Autoimmune Disorders Treatment Market Size by Application
6 Europe
6.1 Europe Autoimmune Disorders Treatment Market Size (2014-2019)
6.2 Autoimmune Disorders Treatment Key Players in Europe
6.3 Europe Autoimmune Disorders Treatment Market Size by Type
6.4 Europe Autoimmune Disorders Treatment Market Size by Application
7 China
7.1 China Autoimmune Disorders Treatment Market Size (2014-2019)
7.2 Autoimmune Disorders Treatment Key Players in China
7.3 China Autoimmune Disorders Treatment Market Size by Type
7.4 China Autoimmune Disorders Treatment Market Size by Application
8 Japan
8.1 Japan Autoimmune Disorders Treatment Market Size (2014-2019)
8.2 Autoimmune Disorders Treatment Key Players in Japan
8.3 Japan Autoimmune Disorders Treatment Market Size by Type
8.4 Japan Autoimmune Disorders Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Autoimmune Disorders Treatment Market Size (2014-2019)
9.2 Autoimmune Disorders Treatment Key Players in Southeast Asia
9.3 Southeast Asia Autoimmune Disorders Treatment Market Size by Type
9.4 Southeast Asia Autoimmune Disorders Treatment Market Size by Application
10 India
10.1 India Autoimmune Disorders Treatment Market Size (2014-2019)
10.2 Autoimmune Disorders Treatment Key Players in India
10.3 India Autoimmune Disorders Treatment Market Size by Type
10.4 India Autoimmune Disorders Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Autoimmune Disorders Treatment Market Size (2014-2019)
11.2 Autoimmune Disorders Treatment Key Players in Central & South America
11.3 Central & South America Autoimmune Disorders Treatment Market Size by Type
11.4 Central & South America Autoimmune Disorders Treatment Market Size by Application
12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Autoimmune Disorders Treatment Introduction
12.1.4 Abbott Laboratories Revenue in Autoimmune Disorders Treatment Business (2014-2019)
12.1.5 Abbott Laboratories Recent Development
12.2 Roche Diagnostics
12.2.1 Roche Diagnostics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Autoimmune Disorders Treatment Introduction
12.2.4 Roche Diagnostics Revenue in Autoimmune Disorders Treatment Business (2014-2019)
12.2.5 Roche Diagnostics Recent Development
12.3 Siemens Healthcare
12.3.1 Siemens Healthcare Company Details
12.3.2 Company Description and Business Overview
12.3.3 Autoimmune Disorders Treatment Introduction
12.3.4 Siemens Healthcare Revenue in Autoimmune Disorders Treatment Business (2014-2019)
12.3.5 Siemens Healthcare Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Company Details
12.4.2 Company Description and Business Overview
12.4.3 Autoimmune Disorders Treatment Introduction
12.4.4 Johnson & Johnson Revenue in Autoimmune Disorders Treatment Business (2014-2019)
12.4.5 Johnson & Johnson Recent Development
12.5 Boehringer Ingelheim
12.5.1 Boehringer Ingelheim Company Details
12.5.2 Company Description and Business Overview
12.5.3 Autoimmune Disorders Treatment Introduction
12.5.4 Boehringer Ingelheim Revenue in Autoimmune Disorders Treatment Business (2014-2019)
12.5.5 Boehringer Ingelheim Recent Development
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Company Details
12.6.2 Company Description and Business Overview
12.6.3 Autoimmune Disorders Treatment Introduction
12.6.4 GlaxoSmithKline Revenue in Autoimmune Disorders Treatment Business (2014-2019)
12.6.5 GlaxoSmithKline Recent Development
12.7 AstraZeneca
12.7.1 AstraZeneca Company Details
12.7.2 Company Description and Business Overview
12.7.3 Autoimmune Disorders Treatment Introduction
12.7.4 AstraZeneca Revenue in Autoimmune Disorders Treatment Business (2014-2019)
12.7.5 AstraZeneca Recent Development
12.8 Sanofi
12.8.1 Sanofi Company Details
12.8.2 Company Description and Business Overview
12.8.3 Autoimmune Disorders Treatment Introduction
12.8.4 Sanofi Revenue in Autoimmune Disorders Treatment Business (2014-2019)
12.8.5 Sanofi Recent Development
12.9 Merck
12.9.1 Merck Company Details
12.9.2 Company Description and Business Overview
12.9.3 Autoimmune Disorders Treatment Introduction
12.9.4 Merck Revenue in Autoimmune Disorders Treatment Business (2014-2019)
12.9.5 Merck Recent Development
12.10 Pfizer
12.10.1 Pfizer Company Details
12.10.2 Company Description and Business Overview
12.10.3 Autoimmune Disorders Treatment Introduction
12.10.4 Pfizer Revenue in Autoimmune Disorders Treatment Business (2014-2019)
12.10.5 Pfizer Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Autoimmune Disorders Treatment Key Market Segments
Table Key Players Autoimmune Disorders Treatment Covered
Table Global Autoimmune Disorders Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Autoimmune Disorders Treatment Market Size Market Share by Type 2014-2025
Figure Bridge therapy Figures
Table Key Players of Bridge therapy
Figure Recombinant technology Figures
Table Key Players of Recombinant technology
Figure Fecal bacteriotherapy Figures
Table Key Players of Fecal bacteriotherapy
Figure Hematopoietic stem-cell transplantation Figures
Table Key Players of Hematopoietic stem-cell transplantation
Figure Phototherapy Figures
Table Key Players of Phototherapy
Figure Helminthic therapy Figures
Table Key Players of Helminthic therapy
Figure Activation-induced assays Figures
Table Key Players of Activation-induced assays
Figure Cytometry by time-of-flight mass spectrometry Figures
Table Key Players of Cytometry by time-of-flight mass spectrometry
Table Global Autoimmune Disorders Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Systemic autoimmune diseases Case Studies
Figure Localized autoimmune diseases Case Studies
Figure Autoimmune Disorders Treatment Report Years Considered
Table Global Autoimmune Disorders Treatment Market Size 2014-2025 (Million US$)
Figure Global Autoimmune Disorders Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Autoimmune Disorders Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Autoimmune Disorders Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Autoimmune Disorders Treatment Market Share by Regions 2014-2019
Figure Global Autoimmune Disorders Treatment Market Share by Regions 2014-2019
Figure Global Autoimmune Disorders Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Autoimmune Disorders Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Autoimmune Disorders Treatment Market Share by Manufacturers (2014-2019)
Figure Global Autoimmune Disorders Treatment Market Share by Manufacturers in 2018
Table Global Autoimmune Disorders Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Autoimmune Disorders Treatment Product/Solution/Service
Table Date of Enter into Autoimmune Disorders Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Autoimmune Disorders Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Autoimmune Disorders Treatment Market Size Share by Type (2014-2019)
Figure Global Autoimmune Disorders Treatment Market Size Market Share by Type (2014-2019)
Table Global Autoimmune Disorders Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Autoimmune Disorders Treatment Market Size Share by Application (2014-2019)
Figure Global Autoimmune Disorders Treatment Market Size Market Share by Application (2014-2019)
Figure Global Autoimmune Disorders Treatment Revenue Market Share by Application in 2018
Figure United States Autoimmune Disorders Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Autoimmune Disorders Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Autoimmune Disorders Treatment Market Share (2018-2019)
Table United States Autoimmune Disorders Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Autoimmune Disorders Treatment Market Share by Type (2014-2019)
Table United States Autoimmune Disorders Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Autoimmune Disorders Treatment Market Share by Application (2014-2019)
Figure Europe Autoimmune Disorders Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Autoimmune Disorders Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Autoimmune Disorders Treatment Market Share (2018-2019)
Table Europe Autoimmune Disorders Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Autoimmune Disorders Treatment Market Share by Type (2014-2019)
Table Europe Autoimmune Disorders Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Autoimmune Disorders Treatment Market Share by Application (2014-2019)
Figure China Autoimmune Disorders Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Autoimmune Disorders Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Autoimmune Disorders Treatment Market Share (2018-2019)
Table China Autoimmune Disorders Treatment Market Size by Type (2014-20189) (Million US$)
Table China Autoimmune Disorders Treatment Market Share by Type (2014-2019)
Table China Autoimmune Disorders Treatment Market Size by Application (2014-2019) (Million US$)
Table China Autoimmune Disorders Treatment Market Share by Application (2014-2019)
Figure Japan Autoimmune Disorders Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Autoimmune Disorders Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Autoimmune Disorders Treatment Market Share (2018-2019)
Table Japan Autoimmune Disorders Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Autoimmune Disorders Treatment Market Share by Type (2014-2019)
Table Japan Autoimmune Disorders Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Autoimmune Disorders Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Autoimmune Disorders Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Autoimmune Disorders Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Autoimmune Disorders Treatment Market Share (2018-2019)
Table Southeast Asia Autoimmune Disorders Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Autoimmune Disorders Treatment Market Share by Type (2014-2019)
Table Southeast Asia Autoimmune Disorders Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Autoimmune Disorders Treatment Market Share by Application (2014-2019)
Figure India Autoimmune Disorders Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Autoimmune Disorders Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Autoimmune Disorders Treatment Market Share (2018-2019)
Table India Autoimmune Disorders Treatment Market Size by Type (2014-2019) (Million US$)
Table India Autoimmune Disorders Treatment Market Share by Type (2014-2019)
Table India Autoimmune Disorders Treatment Market Size by Application (2014-2019) (Million US$)
Table India Autoimmune Disorders Treatment Market Share by Application (2014-2019)
Figure Central & South America Autoimmune Disorders Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Autoimmune Disorders Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Autoimmune Disorders Treatment Market Share (2018-2019)
Table Central & South America Autoimmune Disorders Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Autoimmune Disorders Treatment Market Share by Type (2014-2019)
Table Central & South America Autoimmune Disorders Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Autoimmune Disorders Treatment Market Share by Application (2014-2019)
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Autoimmune Disorders Treatment Business (2014-2019) (Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Autoimmune Disorders Treatment Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Roche Diagnostics Company Details
Table Roche Diagnostics Revenue in Autoimmune Disorders Treatment Business (2014-2019)(Million US$)
Figure Roche Diagnostics Revenue Growth Rate in Autoimmune Disorders Treatment Business (2014-2019)
Table Roche Diagnostics Recent Development
Table Siemens Healthcare Company Details
Table Siemens Healthcare Revenue in Autoimmune Disorders Treatment Business (2014-2019)(Million US$)
Figure Siemens Healthcare Revenue Growth Rate in Autoimmune Disorders Treatment Business (2014-2019)
Table Siemens Healthcare Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Autoimmune Disorders Treatment Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Autoimmune Disorders Treatment Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Autoimmune Disorders Treatment Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Autoimmune Disorders Treatment Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Autoimmune Disorders Treatment Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Autoimmune Disorders Treatment Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Autoimmune Disorders Treatment Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Autoimmune Disorders Treatment Business (2014-2019)
Table AstraZeneca Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Autoimmune Disorders Treatment Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Autoimmune Disorders Treatment Business (2014-2019)
Table Sanofi Recent Development
Table Merck Company Details
Table Merck Revenue in Autoimmune Disorders Treatment Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Autoimmune Disorders Treatment Business (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Autoimmune Disorders Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Autoimmune Disorders Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Global Autoimmune Disorders Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Autoimmune Disorders Treatment Market Size Share by Regions (2019-2025)
Figure Global Autoimmune Disorders Treatment Market Size Share by Regions in 2025
Figure United States Autoimmune Disorders Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Autoimmune Disorders Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Autoimmune Disorders Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Autoimmune Disorders Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Autoimmune Disorders Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Autoimmune Disorders Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Autoimmune Disorders Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Autoimmune Disorders Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Autoimmune Disorders Treatment Market Size by Product (2019-2025)
Figure Global Autoimmune Disorders Treatment Market Size by Product in 2025
Table Global Autoimmune Disorders Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Autoimmune Disorders Treatment Market Size by Application (2019-2025)
Figure Global Autoimmune Disorders Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
造血幹細胞移植 (HSCT)の世界市場：市場規模・現状・予測 Hematopoietic stem cell transplants (HSCT) present to a valid treatment for several congenital and other hematopoietic system disorders, post chemotherapy, and immune sensitive diseases. HSCT is also preferred for replacement of cellular components and deficient cells. The indications for HSCT thus …- 造血幹細胞移植 (HSCT)の世界市場：市場規模・現状・予測 Hematopoietic stem cell transplants (HSCT) present to a valid treatment for several congenital and other hematopoietic system disorders, post chemotherapy, and immune sensitive diseases. HSCT is also preferred for replacement of cellular components and deficient cells. The indications for HSCT thus …
- 変形性関節症向け幹細胞療法の世界市場：市場規模・現状・予測 Osteoarthritis is one of the chronic conditions for joints which results in the breakdown and eventual loss of the cartilage of one or more joints. This can affect joints including hips, lower back, neck, small joints of the fingers, and the base of the thumb and big toe.The expected growth is becau…
- 多発性硬化症向け幹細胞療法の世界市場：市場規模・現状・予測 Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…
- 糖尿病及び関連疾患向け幹細胞療法の世界市場：市場規模・現状・予測 Diabetes is the metabolic disorder that is associated with the glucose level in the blood. It is mainly divided into two types, insulin-dependent diabetes mellitus or juvenile onset (type 1) and non-insulin-dependent diabetes mellitus, or adult-onset diabetes (type 2).NSI-566 is the stem cell therap…